Antiepileptic-drug tapering and seizure recurrence: Correlation with serum drug levels and biomarkers in persons with epilepsy

Indian J Pharmacol. 2022 Jan-Feb;54(1):24-32. doi: 10.4103/ijp.ijp_253_21.

Abstract

Objectives: Antiepileptic-drug (AED) serum level and inflammatory biomarkers are primarily monitored/assessed during epilepsy treatment for effective seizure control; however, their correlation with seizure recurrence (SR) following AED-tapering has not been established, and this is being investigated in this study.

Materials and methods: This prospective observational study enrolled persons with epilepsy (PWE) on AED monotherapy and going to start tapering after being seizure-free for ≥2 years. Data regarding seizure episodes, AED-treatment, and adverse events (using Liverpool Adverse Event profile [LAEP]-score) were recorded. Serum AED levels using high-performance liquid chromatography and biomarkers levels through enzyme-linked immunosorbent assay kits were estimated at AED-tapering commencement and at 6 months/SR time.

Results: Among 129 enrolled PWE (levetiracetam [n = 52], valproate [n = 34], carbamazepine [n = 29], and phenytoin [n = 14]), SR occurred in 23.3% during follow-up (range 12-44 months). PWE with subtherapeutic serum AED level at the onset of tapering had higher SR (P = 0.004) than those with therapeutic or higher levels. Levetiracetam-treated PWEs with SR have significantly low AED levels than PWE with no-SR (P < 0.001). PWE had significantly raised inflammatory biomarkers (interleukin [IL]-1 β, tumor necrosis factor [TNF]-α, IL-6, and high-mobility group box protein 1) and decreased IL-10 than healthy control subjects. SR and no-SR groups did not differ significantly in inflammatory markers except for higher IL-1 β and TNF-α levels in SR group (P = 0.001, 0.02, respectively). Improvement in LAEP score was observed in follow-up visits without any difference between SR and no-SR groups.

Conclusion: Low serum AED levels (especially levetiracetam) and raised levels of TNF-α and IL-1 β during tapering commencement had a higher association with SR following AED-tapering.

Keywords: Antiepileptic drug tapering; inflammatory biomarkers; persons with epilepsy; seizure recurrence; serum antiepileptic-drug level.

Publication types

  • Observational Study

MeSH terms

  • Anticonvulsants* / adverse effects
  • Biomarkers
  • Drug Tapering
  • Epilepsy* / drug therapy
  • Humans
  • Interleukin-1beta / therapeutic use
  • Levetiracetam / therapeutic use
  • Recurrence
  • Seizures / chemically induced
  • Seizures / drug therapy
  • Tumor Necrosis Factor-alpha

Substances

  • Anticonvulsants
  • Biomarkers
  • Interleukin-1beta
  • Tumor Necrosis Factor-alpha
  • Levetiracetam